Clinical Trial

The Alternative Effects of Electroacupuncture in the Treatment of Trigeminal Neuralgia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Trigeminal neuralgia (TN), characterized by its refractory nature and recurrence, frequently leads to anxiety, depression, and insomnia, thereby significantly diminishing patients' quality of life and potentially inducing self-harm. Carbamazepine (CBZ) is the first-line medication for TN, yet it presents adverse effects such as addiction and the absence of analgesic effects upon cessation. Acupuncture, particularly electroacupuncture(EA), has demonstrated efficacy in TN treatment, although its therapeutic outcomes are influenced by various factors. Consequently, this study aims to evaluate the clinical efficacy of EA for TN and its potential as an alternative to CBZ treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-11; most recent amendment 2026-03-02.
Trial Details
NCT Number NCT06977932
Lead Sponsor Yuanyuan Wu
Collaborators: Pingyang County Traditional Chinese Medicine Hospital, Jiaxing Hospital of Traditional Chinese Medicine
Conditions Trigeminal Neuralgia
Enrollment 126 participants
Start Date 2026-03-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-05